Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 15 Aug 2026 Identification of new Trypanosoma cruzi-specific protein synthesis inhibitors by using a developed high-throughput in vitro translation assay International Journal for Parasitology: Drugs and Drug Resistance
Scientific articles 5 Aug 2026 ICH E21: from landmark guidance to specific action for maternal and child health
Scientific articles 3 Aug 2026 A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms Infectious Diseases and Therapy
Press releases 18 May 2009 Sanofi-aventis and DNDi enter into a Collaboration Agreement on a New Drug for Sleeping Sickness, Fexinidazole
Press releases 15 May 2009 UK Government (DFID) Renews Multi-Year Support of DNDi to Improve Medicines for the Most Neglected
Press releases 15 May 2009 NECT Added to WHO Essential Medicines List as Combination Treatment Against Sleeping Sickness
Press releases 11 Dec 2008 SCYNEXIS and DNDi Extend Collaboration to Identify Drug Candidates to Treat Sleeping Sickness
Press releases 16 Oct 2008 Coarsucam™ (artesunate/amodiaquine) first fixed-dose antimalarial combination to receive WHO Prequalification
Press releases 13 Oct 2008 Indian Scientists Catalyse Efforts in Research and Development for New Treatments for Neglected Diseases
Press releases 21 Jul 2008 Sanofi-aventis and DNDi welcome the Clinton Foundation announcement on ACTs and commit to providing fixed-dose combination “ASAQ” at equally low prices
Press releases 21 Jul 2008 Chagas Disease Partnership Will Deliver Safe, Easy-to-Use Treatment for Children
Press releases 26 Jun 2008 DNDi calls on G8 leaders to increase their commitment to neglected tropical diseases
Press releases 23 Jun 2008 DNDi Partners With Pharma, Biotech, Academia, Public Health Institutes & NGOs to Deliver Lifesaving Drugs
Press releases 4 Jun 2008 The University of North Carolina and DNDi Agree to Synergize Novel R&D Efforts to Develop Drugs for the Most Neglected
Press releases 8 May 2008 DNDi Receives Goodwin Award for Its Social Entrepeneurial Approach for the Most Neglected
Press releases 17 Apr 2008 A Worldwide Public Partnership Makes Available a New, Once-a-Day Fixed-Dose Combination against Malaria
